Cellenkos, KFSHRC sign MOU to Advance T Regulatory Cell Therapies
KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host Disease King Faisal Specialist Hospital and Research Centre and Cellenkos, a Texas based clinical stage biotech company, have signed...